Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 311 citing articles:

The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
Gin S. Malhi, Erica Bell, Darryl Bassett, et al.
Australian & New Zealand Journal of Psychiatry (2020) Vol. 55, Iss. 1, pp. 7-117
Closed Access | Times Cited: 399
Time for united action on depression: a Lancet–World Psychiatric Association Commission
Helen Herrman, Vikram Patel, Christian Kieling, et al.
The Lancet (2022) Vol. 399, Iss. 10328, pp. 957-1022
Open Access | Times Cited: 284
Tapering of SSRI treatment to mitigate withdrawal symptoms
Mark Horowitz, David Taylor
The Lancet Psychiatry (2019) Vol. 6, Iss. 6, pp. 538-546
Open Access | Times Cited: 203
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Fiammetta Cosci, Guy Chouinard
Psychotherapy and Psychosomatics (2020) Vol. 89, Iss. 5, pp. 283-306
Open Access | Times Cited: 201
The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis
Simon B. Goldberg, Brian T. Pace, Christopher R. Nicholas, et al.
Psychiatry Research (2020) Vol. 284, pp. 112749-112749
Closed Access | Times Cited: 181
Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis
Jonathan Henssler, Yannick Schmidt, Urszula Schmidt, et al.
The Lancet Psychiatry (2024) Vol. 11, Iss. 7, pp. 526-535
Closed Access | Times Cited: 26
Depression and Anxiety Disorders
Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal
(2025), pp. 335-476
Closed Access | Times Cited: 7
Should antidepressants be used for major depressive disorder?
Janus Christian Jakobsen, Christian Gluud, Irving Kirsch
BMJ evidence-based medicine (2019) Vol. 25, Iss. 4, pp. 130-130
Open Access | Times Cited: 131
Depressive disorders: Treatment failures and poor prognosis over the last 50 years
Thomas P. Blackburn
Pharmacology Research & Perspectives (2019) Vol. 7, Iss. 3
Open Access | Times Cited: 109
Microdosing psychedelics: Motivations, subjective effects and harm reduction
Toby Lea, Nicole Amada, Henrik Jungaberle, et al.
International Journal of Drug Policy (2019) Vol. 75, pp. 102600-102600
Closed Access | Times Cited: 87
Antidepressant Withdrawal and Rebound Phenomena
Jonathan Henssler, Andreas Heinz, Lasse Brandt, et al.
Deutsches Ärzteblatt international (2019)
Open Access | Times Cited: 86
Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults
Ellen Van Leeuwen, Mieke L van Driel, Mark Horowitz, et al.
Cochrane library (2021) Vol. 2021, Iss. 4
Open Access | Times Cited: 76
Exploring the Role and Potential of Probiotics in the Field of Mental Health: Major Depressive Disorder
Dinyadarshini Johnson, Sivakumar Thurairajasingam, Vengadesh Letchumanan, et al.
Nutrients (2021) Vol. 13, Iss. 5, pp. 1728-1728
Open Access | Times Cited: 70
What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications
Adele Framer
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 56
Distinguishing relapse from antidepressant withdrawal: clinical practice and antidepressant discontinuation studies
Mark Horowitz, David Taylor
BJPsych Advances (2022) Vol. 28, Iss. 5, pp. 297-311
Open Access | Times Cited: 47
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data
Mark Horowitz, Adele Framer, Michael P. Hengartner, et al.
CNS Drugs (2022) Vol. 37, Iss. 2, pp. 143-157
Open Access | Times Cited: 45
Re-thinking lactation-related nipple pain and damage
Pamela Douglas
Women s Health (2022) Vol. 18
Open Access | Times Cited: 40
Primary care healthcare professionals supporting patients to discontinue antidepressants: A scoping review of barriers, enablers and interventions
Bethany Atkins, Michelle Maden, Linda Birt, et al.
Research in Social and Administrative Pharmacy (2025)
Closed Access | Times Cited: 1
Managing Antidepressant Discontinuation: A Systematic Review
Emma Maund, Beth Stuart, Michael Moore, et al.
The Annals of Family Medicine (2019) Vol. 17, Iss. 1, pp. 52-60
Open Access | Times Cited: 70
Strategies to reduce use of antidepressants
Tony Kendrick
British Journal of Clinical Pharmacology (2020) Vol. 87, Iss. 1, pp. 23-33
Open Access | Times Cited: 66
The ‘patient voice’: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition
Anne Guy, Marion Brown, Stevie Lewis, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 61
May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance
Giovanni A. Fava
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 59
How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding
Michael P. Hengartner
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 57
The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services?
Edward White, John Read, Sherry Julo
Therapeutic Advances in Psychopharmacology (2021) Vol. 11, pp. 204512532098117-204512532098117
Open Access | Times Cited: 54
The relationship between dose and serotonin transporter occupancy of antidepressants—a systematic review
Anders Sørensen, Henricus G. Ruhé, Klaus Munkholm
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 192-201
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top